1/12
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Viruses: Fact card
non living
protein/lipid coated
mutation is frequent (resistance is common)
contains replication material only
enters healthy human cells to survive
replicate using host cell infrastructure
tx must reach virus prior to entering host cell
disable viral release
Influenza: about
contagious
20% of pop. gets infected annually
mortality risk increases in immunocompromised
virus family
Orthomyxoviridae
type A and B = 8 RNA segments
type C = 7 RNA segments
2 subtypes: NA, HA
can sometimes spread from animals to humans (bird flu)
upper airway - destroys mucosal + epithelial cells
lower airway - destroys cells like alveolar
risk of complex pneumonia
allows for opportunistic infections
bacterial or fungal
Influenza: s&s
profound malaise, common cold symptoms, fever
severe: diaphoresis, myalgia, tachycardia, hypoxia
complications → sinusitis, otitis media, pneumonia, bronchitis
Influenza: TX
supportive
antipyretics, analgesics, decongestants, antitussives
antivirals
oseltamivir (Tamiflu)
zanamivir (Ralenza)
neurominidase inhibitors - decrease viral release
as prophylaxis - decrease duration only
hydrate
o2 if impaired gas exchange
influenza vaccine - annual per subtype
Pneumonia: etiology, about
either nosocomial or community acquired
either bacterial or viral
bacterial
typical pneumonia
alveoli fill w/ exudate
more common and serious than viral
immunizations target many bacterial strains
pathogens
s. pneumoniae
haemophilus influenza
s. aureus
viral
atypical pneumonia
sometimes atypical can mean atypical bacteria (mycoplasms)
affects lower resp. - alveoli, bronchioles
Pneumonia: DX and TX
DX:
assess for proper oxygenation
fever, malaise, wet cough = exudate s&s
and xray!! (white = exudate)
bacterial pneumonia
localized
denser white areas
viral pneumonia
spread out
hazy, cloudy
covid-19 pneumonia
bilateral, peripheral
worse in lower lungs
hazy
TX:
according to pathogen
vaccines
pneumoccal conjugate
Hib
Influenza
empiric tx
macrolides (inhibiting protein synthesis)
Cyanosis: Peripheral, Central, Causes
Peripheral
low o2 (<92%)
upper/lower extremities
fingers, toes, lips
NOT mucosa
can be normal
Central
low o2 (<85%)
oral mucosa
NEVER normal
other body parts
Causes
low perfusion
vasoconstriction
low CO
low O2 due to pathology
pneumonia
asthma
CAUTION
oxygenation failure → hypoxemia → organ ischemia
Protein Synthesis Inhibitors: Macrolides
‘-mycin’ suffix
tx efficacy
community acquired adult pneumonia
other infections - gonorrhea
meds
erythromycin
azithromycin (Zithromax)
clarithromycin (Biaxin)
Aspiration Pneumonia: etiology and risks
lung infection by inhaling foreign particles into airways
= inflammation + bacterial infection
innate reflexes protect against aspiration
increase risk
immunocomprised
taking antitussives (suppress cough reflex)
position (lying when eating)
eating disorders
CNS impairment of protective reflexes
drug-induced sedation/anesthesia
stroke/CVA
head injury
Aspiration Pneumonia: TX
bugsanddrugs
metronidazole/Flagyl (nucleic acid replication/transription inhibitor)
TB: about
Affects lungs, but any other organ can be infected
Pathogen
bacteria
Mycobacterium tubercolosis
diff to penetrate outer shell
aerobic + airborne
Contagious
LOTS of cases and annual deaths
very resistant
TB: infection process
inhaled, deposits into alveoli = Active TB
phagocytosis via macrophages
immune response forms localized granuloma lesions (ghon foci)
ultimate necrosis of lung tissue (see on xray)
Latent TB
not infectious to others
necrosed tissue harbors the pathogen
Secondary TB
latent becomes active again
TB: s&s, TX, DX
1st s&s
malaise, cough, anorexia
Dx
x-ray
culture: sputum, bloof
Tuberculin skin test
shows existence of immune response
not marker for active infection
once exposed, often + foreva
TX
6-12 months
Isoniazid (INH)
Cell wall inhibitor
Rifampin
DNA synthesis inhibitor
anti-TB meds
but there are more resistant strains